Journal of thrombosis and haemostasis : JTH · 2025
Prothrombotic fibrin clot phenotype as a risk factor for persistent left ventricular thrombus following acute myocardial infarction.
СтатьяНаблюдательное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Mróz Krystian, Paszek Elżbieta, Polak Maciej, Undas Anetta
Аннотация
BACKGROUND: Left ventricular thrombus (LVT) occurs in up to 15% of ST-segment elevation myocardial infarction (MI) patients and may persist in 30% despite anticoagulation. We hypothesized that formation of dense and poorly lysable fibrin clots may contribute to this phenomenon.
OBJECTIVES: We investigated whether unfavorable fibrin clot properties and their determinants are associated with resolution of LVT on anticoagulation.
METHODS: We included 149 consecutive patients with LVT during acute MI referred for diagnostic workup. Three months after MI, we determined plasma fibrin clot permeability (Ks), clot lysis time (CLT), and plasminogen activator inhibitor-1, along with citrullinated histone H3, a marker of NETosis. LVT resolution was assessed on enrollment (after 3 months of anticoagulation, mostly with direct oral anticoagulants [n = 121, 82%]) and 3 months thereafter.
RESULTS: Patients with LVT visible at 3 months (n = 75, 50.3%) were characterized by lower Ks (-15.5%) and longer CLT (+30%), along with higher plasminogen activator inhibitor-1 (+42.4%) and citrullinated histone H3 (+33.3%), without differences in the type of anticoagulation. At 6 months after MI on continued anticoagulation, LVT was visible in 44 (29.7%) of patients, who had an unfavorable clot phenotype compared with individuals with resolved LVT. Lower Ks and longer CLT were associated with LVT persistence at 3 and 6 months, irrespective of potential confounding factors.
CONCLUSIONS: This is the first study to demonstrate that prothrombotic fibrin clot properties, which might be related to enhanced NETosis, are associated with anticoagulation failure in patients with LVT complicating acute MI.
OBJECTIVES: We investigated whether unfavorable fibrin clot properties and their determinants are associated with resolution of LVT on anticoagulation.
METHODS: We included 149 consecutive patients with LVT during acute MI referred for diagnostic workup. Three months after MI, we determined plasma fibrin clot permeability (Ks), clot lysis time (CLT), and plasminogen activator inhibitor-1, along with citrullinated histone H3, a marker of NETosis. LVT resolution was assessed on enrollment (after 3 months of anticoagulation, mostly with direct oral anticoagulants [n = 121, 82%]) and 3 months thereafter.
RESULTS: Patients with LVT visible at 3 months (n = 75, 50.3%) were characterized by lower Ks (-15.5%) and longer CLT (+30%), along with higher plasminogen activator inhibitor-1 (+42.4%) and citrullinated histone H3 (+33.3%), without differences in the type of anticoagulation. At 6 months after MI on continued anticoagulation, LVT was visible in 44 (29.7%) of patients, who had an unfavorable clot phenotype compared with individuals with resolved LVT. Lower Ks and longer CLT were associated with LVT persistence at 3 and 6 months, irrespective of potential confounding factors.
CONCLUSIONS: This is the first study to demonstrate that prothrombotic fibrin clot properties, which might be related to enhanced NETosis, are associated with anticoagulation failure in patients with LVT complicating acute MI.